ORs and 95% CIs Obtained With TORMs of PDI <55

EpochEpoch, OR (95% CI)
AntenatalNeonatal (First 28 d)36 wk PMA
    Single mother1.8 (1.02–3.0)1.8 (0.95–3.5)1.8 (0.9–3.5)
    Complete antenatal corticosteroids2.3 (1.5–3.5)2.4 (1.5–3.9)2.4 (1.5–3.8)
    Preeclampsia or fetal indication2.2 (1.5–3.1)2.3 (1.7–3.3)2.2 (1.5–3.2)
Neonatal (first 28 d)
    Pneumothorax1.9 (1.1–3.5)1.9 (1.1–3.3)
    PIE2.2 (1.04–4.7)2.0 (0.99–4.2)
    PD3.6 (1.2–7.6)2.7 (1.1–6.5)
    EPPD3.0 (1.2–7.6)2.7 (1.1–6.5)
36 wk PMA
    CLD without MV1.1 (0.6–2.0)
    CLD with MV1.9 (0.97–3.9)
  • These analyses include only those children without a severe gross motor impairment (GMFCS score < 1). Antenatal epoch includes the following variables: gestational age of 23–24 weeks; gestational age of 25–26 weeks; single mother; complete course of antenatal corticosteroids; cesarean delivery; and delivery for preeclampsia or fetal indications. Neonatal epoch includes the following variables: SNAP-II in the top quartile; MV or high-frequency ventilation at 7 days; late bacteremia; pneumothorax; PIE; Pao2 in the lowest quartile (week 1); Pao2 missing (week 1); transfusions (packed red blood cells); PD; EPPD; ventriculomegaly; echolucent lesion; echodense lesion; NEC stage II or worse; methylxanthine; PDA; and PDA ligation. Thirty-six weeks' PMA epoch includes the following variables: CLD without MV (CMV or high-frequency ventilation) at 36 weeks and CLD with MV.